Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SOX5 antisense RNA 1 (SOX5-AS1) is a long non-coding RNA (lncRNA) transcribed from the locus antisense to the SOX5 gene. Like other antisense RNAs, SOX5-AS1 is presumed to regulate the expression of its sense counterpart (SOX5) and potentially other loci via mechanisms such as transcriptional interference, chromatin modification, and RNA-RNA interactions. Antisense lncRNAs often function in *cis* at their site of synthesis to modulate gene transcription, commonly affecting chromatin structure, transcription elongation, or promoter accessibility[2]. Although SOX5 protein itself plays significant roles in cancer biology as an oncogenic transcription factor, the specific role of SOX5-AS1 is less well characterized in the literature currently available. However, based on the biological paradigms of antisense lncRNAs, SOX5-AS1 likely participates in regulation of SOX5 gene expression and could thereby indirectly contribute to pathological processes such as tumor progression if aberrantly regulated[2]. There is no current evidence available indicating that SOX5-AS1 is a direct therapeutic target, biomarker, or drug-interacting molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SOX5 antisense RNA 1 (SOX5-AS1).